Login
$EW
$90.82 +$0.26 (0.29%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Bernard Zovighian Also a director
CEO
Title from the Form 4 dated Jul 27, 2026
58 Not stated Not stated Not reported
Scott B. Ullem
CVP, Chief Financial Officer
Title from the Form 4 dated May 11, 2026
59 Not stated Not stated Not reported
Theodora Mistras
CVP, Chief Financial Officer
Title from the Form 4 dated Jul 9, 2026
Not stated Not stated Not stated Not reported
Andrew M. Dahl
SVP, Corporate Controller
Title from the Form 4 dated Sep 13, 2026
Not stated Not stated Not stated Not reported
Annette M. Brüls
Corporate Vice President, Europe, Middle East, Africa, Canada and Latin America (EMEACLA)
54 Since 2024
2 years
Not stated $3,732,107
Donald E. Bobo, Jr.
CVP,Strategy/Corp Development
Title from the Form 4 dated May 27, 2026
64 Not stated 1995 Not reported
Daveen Chopra
CVP, TMTT, Surgical & IHFM
Title from the Form 4 dated Sep 11, 2026
47 Not stated Not stated Not reported
Daniel Lippis
CVP, TAVR
Title from the Form 4 dated Oct 8, 2026
50 Not stated 2010 Not reported
Wayne T. Markowitz
CVP, JAPAC
Title from the Form 4 dated Sep 11, 2026
54 Not stated Not stated Not reported
Annette Bruls
CVP, EMEACLA
Title from the Form 4 dated Aug 28, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
Not stated
the proxy does not say
Average tenure
6.9 years
from year joined
CEO also chairs the board
No
Nicholas J. Valeriani
Director Age On board Independent Committees Other public boards Pay Source
Nicholas J. Valeriani
69 2014
12 years
Not stated
Compensation and Governance Committee
None stated Not stated
Bernard Zovighian
58 2023
3 years
Not stated None stated None stated Paid as CEO
Leslie C. Davis
67 2024
2 years
Not stated
Compensation and Governance Committee
None stated Not stated
David T. Feinberg
64 2024
2 years
Not stated
Audit Committee
Humana Inc. Not stated
Kieran T. Gallahue
62 2015
11 years
Not stated
Audit Committee
Envista Holdings Corporation Not stated
Leslie S. Heisz
65 2016
10 years
Not stated
Audit Committee · Chair
Ingram Micro Holding Corporation Not stated
Paul A. LaViolette
68 2020
6 years
Not stated
Compensation and Governance Committee · Chair
Pulse Biosciences, Inc. Not stated
Steven R. Loranger
74 2016
10 years
Not stated
Compensation and Governance Committee
None stated Not stated
Ramona Sequeira
60 2020
6 years
Not stated
Audit Committee
Organon & Co., Novo Nordisk A/S Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 26, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support